Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating revenues:    
License revenues
Operating expenses:    
Research and development 2,607 791
General and administrative 814 515
Total operating expense 3,421 1,306
Operating loss (3,421) (1,306)
Other (income) expense:    
Governmental assistance - research incentives (174) (731)
Other (income) expense, net (4) 35
Change in fair value of warrant liability 39
Total other (income) expense (178) (657)
Loss before income tax expense (3,243) (649)
Income tax expense 9 1
Net loss (3,252) (650)
Other comprehensive income    
Unrealized gain on marketable securities 3
Net loss and comprehensive loss $ (3,249) $ (650)
Basic and diluted net loss per share (in dollars per share) $ (0.27) $ (0.10)
Weighted average shares outstanding – basic and diluted (in shares) 11,956,874 6,546,780